Lakeshore Biopharma Co Ltd (LSB) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access LSB Annual Balance Sheets →
The data below summarizes Lakeshore Biopharma Co Ltd's balance sheet position from Mar 31 2023 to Mar 31 2024, enabling a period-by-period comparison of financial strength.
Quarterly Report, GAAP in USD millions
ITEM
(Mar 31 2024)
0 0 0 (Mar 31 2023)
Assets
Cash & cash equivalent34.72
Other Short-term Investments0.00
Cash & Short-term Investments34.00
Accounts receivable62.60
Other Receivables0.43
Notes Receivable, Current0.00
Inventories28.67
Other Current Assets0.26
Prepaid Expense And Other Assets Current1.04
Total Current Assets127.30
Equipment/Property/Plant Net66.72
Intangible Assets10.04
Tax Assets, Noncurrent0.00
Other Assets, Noncurrent9.20
Total Assets213.25
Liabilities
Accounts Payable, Current AC9.55
Accrued Liabilities And Other Liabilities57.61
Short-term Debt DE144.90
Other Liabilities, Current1.01
Taxes Payable0.00
Total Current Liabilities113.07
Long-term debt13.95
Total Long-term Debt13.95
Derivative Liability, Noncurrent DE0.64
Accrued Income Taxes, Noncurrent0.00
Other liabilities, Noncurrent3.11
Total Liabilities130.77
Stockholders' Equity
Common Stock Value0.00
Additional Paid In Capital Common Stock415.91
Retained Earnings / Accumulated Deficit-325.23
Accumulated Other Comprehensive Income0.00
Defined Benefit Plan and Other17.70
Other Equity-25.90
Common Stockholder's Equity82.48
Total Stockholder's Equity82.48
Liabilities & Stockholder's Equity213.25
4 historic quarters locked

Sign in to unlock the full Lakeshore Biopharma Co Ltd balance sheet history.

About Lakeshore Biopharma Co Ltd Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 20-F filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001213900-25-069880

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.